Glucose responsive insulin (AmideBio)

N/A

Report date: 2024/01/25 10:30:02

Base Information

Drug NameGlucose responsive insulin (AmideBio)
Drug Alias NameABGSI-084AB-GSI-084
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionOrnithine decarboxylase stimulantsProtein-tyrosine kinases inhibitorsPhosphokinases stimulants
TargetsProtein-tyrosine kinasesOrnithine decarboxylasePhosphokinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmideBio LLC
China Registration ClassN/A

Develop Information

Active CompaniesAmideBio LLC
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A